Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Seattle biotech Neovia Oncology has enrolled its first patient into a Phase 1 clinical trial for its lead cancer drug NEV-801, a novel,...
NEOVIA ONCOLOGY Ltd. http://www.neoviaoncology.com/ a privately-held biotechnology company engaged in the development and commercialization of novel, ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.